Major Depressive Disorder Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Major Depressive Disorder stocks.

Major Depressive Disorder Stocks Recent News

Date Stock Title
May 6 LLY Why Eli Lilly Stock Jumped by 4% Today
May 6 LLY $100 Invested In This Stock 15 Years Ago Would Be Worth $2,200 Today
May 6 LLY Eli Lilly First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
May 6 AZN AstraZeneca invests $140M in Cellectis, raising stake to 44%
May 6 NERV Minerva Neurosciences (NERV) Upgraded to Buy: What Does It Mean for the Stock?
May 6 AZN Why Astrazeneca (AZN) is a Top Dividend Stock for Your Portfolio
May 6 LLY Eli Lilly declares $1.30 dividend
May 6 LLY Lilly Declares Second-Quarter 2024 Dividend
May 6 ITCI Intra-Cellular Therapies Q1 2024 Earnings Preview
May 6 LLY Lilly (LLY) Reliance on International Sales: What Investors Need to Know
May 6 AZN AstraZeneca ups stake in Cellectis in latest cell therapy bet
May 6 LLY Investors Pile Into Amgen in Search of Next Obesity Drug Payout
May 6 AZN The Zacks Analyst Blog Highlights AstraZeneca, Qualcomm, FedEx, American International and Baker Hughes
May 6 LLY 2 Top Stocks That Could Make You Richer in 2024
May 6 AZN Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
May 5 LLY 3 Super-Safe Dividend Stocks That Have Been Making Recurring Payments for 130+ Years
May 5 LLY 3 No-Brainer Stocks to Buy in May
May 4 LLY Pharma R&D productivity seen improving for the first time in years - Deloitte
May 4 LLY Eli Lilly: Great Time To Divest Before It Potentially Crashes
May 4 LLY Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making
Major Depressive Disorder

Major depressive disorder (MDD), also known simply as depression, is a mental disorder characterized by at least two weeks of low mood that is present across most situations. It is often accompanied by low self-esteem, loss of interest in normally enjoyable activities, low energy, and pain without a clear cause. People may also occasionally have false beliefs or see or hear things that others cannot. Some people have periods of depression separated by years in which they are normal, while others nearly always have symptoms present. Major depressive disorder can negatively affect a person's personal life, work life, or education, as well as sleeping, eating habits, and general health. Between 2–8% of adults with major depression die by suicide, and about 50% of people who die by suicide had depression or another mood disorder.The cause is believed to be a combination of genetic, environmental, and psychological factors. Risk factors include a family history of the condition, major life changes, certain medications, chronic health problems, and substance abuse. About 40% of the risk appears to be related to genetics. The diagnosis of major depressive disorder is based on the person's reported experiences and a mental status examination. There is no laboratory test for major depression. Testing, however, may be done to rule out physical conditions that can cause similar symptoms. Major depression is more severe and lasts longer than sadness, which is a normal part of life. The United States Preventive Services Task Force (USPSTF) recommends screening for depression among those over the age 12, while a prior Cochrane review found that the routine use of screening questionnaires have little effect on detection or treatment.Typically, people are treated with counseling and antidepressant medication. Medication appears to be effective, but the effect may only be significant in the most severely depressed. It is unclear whether medications affect the risk of suicide. Types of counseling used include cognitive behavioral therapy (CBT) and interpersonal therapy. If other measures are not effective, electroconvulsive therapy (ECT) may be considered. Hospitalization may be necessary in cases with a risk of harm to self and may occasionally occur against a person's wishes.Major depressive disorder affected approximately 216 million people (3% of the world's population) in 2015. The percentage of people who are affected at one point in their life varies from 7% in Japan to 21% in France. Lifetime rates are higher in the developed world (15%) compared to the developing world (11%). It causes the second most years lived with disability, after lower back pain. The most common time of onset is in a person's 20s and 30s. Females are affected about twice as often as males. The American Psychiatric Association added "major depressive disorder" to the Diagnostic and Statistical Manual of Mental Disorders (DSM-III) in 1980. It was a split of the previous depressive neurosis in the DSM-II, which also encompassed the conditions now known as dysthymia and adjustment disorder with depressed mood. Those currently or previously affected may be stigmatized.

Browse All Tags